TY - JOUR
T1 - 3D vertical-flow paper-based device for simultaneous detection of multiple cancer biomarkers by fluorescent immunoassay
AU - Jiao, Yucui
AU - Du, Chao
AU - Zong, Lijun
AU - Guo, Xueying
AU - Han, Yufeng
AU - Zhang, Xiaopan
AU - Li, Lin
AU - Zhang, Chengwu
AU - Ju, Qiang
AU - Liu, Jinhua
AU - Yu, Hai Dong
AU - Huang, Wei
N1 - Publisher Copyright:
© 2019 Elsevier B.V.
PY - 2020/3/1
Y1 - 2020/3/1
N2 - A novel three-dimensional (3D) vertical-flow paper-based device (3VPD), integrated with a sandwich-type fluorescent immunoassay, was developed for multiplexed detection of cancer biomarkers simultaneously based on the principle of origami. The developed 3VPD, composed of a sample layer, a splitting layer, and a test layer, could be fabricated simply by wax-printing on paper at a large scale. Herein, a vertical-flow immunoassay was introduced into the device, in which fluorescein isothiocyanate labeled antibodies were coated on the splitting layer and mouse monoclonal capture antibodies were functionalized on the test layer. The proposed 3VPD showed high sensitivity and selectivity for detecting three cancer biomarkers, carcinoembryonic antigen (CEA), a-fetoprotein (AFP), and cancer antigen 199 (CA199) with detection limits of 0.03 ng/mL, 0.05 ng/mL, and 0.09 U/mL in human serum, respectively. The results obtained in human serum were compatible with the reference values which were acquired from parallel single-analyte. The developed 3VPD provides a new strategy to develop an inexpensive and sensitive approach for simultaneous detection of multiple analytes and comprehensive clinical diagnosis by a single test.
AB - A novel three-dimensional (3D) vertical-flow paper-based device (3VPD), integrated with a sandwich-type fluorescent immunoassay, was developed for multiplexed detection of cancer biomarkers simultaneously based on the principle of origami. The developed 3VPD, composed of a sample layer, a splitting layer, and a test layer, could be fabricated simply by wax-printing on paper at a large scale. Herein, a vertical-flow immunoassay was introduced into the device, in which fluorescein isothiocyanate labeled antibodies were coated on the splitting layer and mouse monoclonal capture antibodies were functionalized on the test layer. The proposed 3VPD showed high sensitivity and selectivity for detecting three cancer biomarkers, carcinoembryonic antigen (CEA), a-fetoprotein (AFP), and cancer antigen 199 (CA199) with detection limits of 0.03 ng/mL, 0.05 ng/mL, and 0.09 U/mL in human serum, respectively. The results obtained in human serum were compatible with the reference values which were acquired from parallel single-analyte. The developed 3VPD provides a new strategy to develop an inexpensive and sensitive approach for simultaneous detection of multiple analytes and comprehensive clinical diagnosis by a single test.
KW - Cancer biomarkers
KW - Fluorescent immunoassay
KW - Multiplexed detection
KW - Paper-based devices
KW - Vertical-flow immunoassay
UR - http://www.scopus.com/inward/record.url?scp=85076857438&partnerID=8YFLogxK
U2 - 10.1016/j.snb.2019.127239
DO - 10.1016/j.snb.2019.127239
M3 - 文章
AN - SCOPUS:85076857438
SN - 0925-4005
VL - 306
JO - Sensors and Actuators B: Chemical
JF - Sensors and Actuators B: Chemical
M1 - 127239
ER -